FROM THE NEWS FEED
Japanese pharma company Otsuka Pharmaceutical announced its acquisition of Transcend Therapeutics, Inc., The post Another Big Pharma Bet on Psychedelics: Otsuka Buys $1.2 Billion MDMA Analog Program appeared first on Psychedelic Health.
Continue to the original publication for the complete article.
KEEP EXPLORING
This article was originally published on Mind Forward.
Compass Pathways, Transcend Therapeutics, and the Usona Institute have been named the first recipients of FDA Nationa...
President Donald J. The post Trump Issues Executive Order to Accelerate Psychedelics for Mental Health appeared firs...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...